“Invisible millions” with hearing loss missing from mainstream media
New global research reveals a major media blind spot: Many people are unable…
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142)…
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful…
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
February 28, 2026 09:45 ET | Source: Cogent Biosciences, Inc. Bezuclastinib mean…
A Decade of India’s Evolving Naval Diplomacy: From SAGAR to MAHASAGAR
NEW DELHI, Feb. 26, 2026 /PRNewswire/ -- Over the past decade, the Indian…
Bank of Baroda, with support from Rocky Mountain Institute, and Climate Policy Initiative Launch Guidebook to Help Indian Banks Assess Corporate Transition Readiness
New guidebook provides practical guidance for Indian financial institutions to evaluate climate…
From Minds to Machines: India’s top CEOs and CHROs chart the AI-Led talent blueprint at ET NexTech Human Capital Summit 2026
NEW DELHI, Feb. 25, 2026 /PRNewswire/ -- The Economic Times NexTech Human…
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
February 23, 2026 17:10 ET | Source: Kyntra Bio FG-3246 and enzalutamide…
Not sure how to give wishes for the Year of the Horse? Let’s hear from CGs in Guangzhou
GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South:…
A taste of Chinese New Year in Guangdong: top picks from Consuls General in Guangzhou
GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South:…
